Frunevetmab

Frunevetmab is a monoclonal antibody used to treat pain associated with osteoarthritis in dogs.Frunevetmab is specifically designed to target nerve growth factors (NGF), which play a crucial role in pain signaling and inflammation. It is administered via injection and is intended for dogs suffering from chronic pain. Read more

Frunevetmab is a monoclonal antibody used to treat pain associated with osteoarthritis in dogs.
Frunevetmab is specifically designed to target nerve growth factors (NGF), which play a crucial role in pain signaling and inflammation. It is administered via injection and is intended for dogs suffering from chronic pain.

Essential insights

• Neutralization of Nerve Growth Factors (NGF): Frunevetmab binds to NGF, preventing its interaction with receptors on nerve endings, thereby reducing pain and inflammation.
• Prolonged Effect: Its targeted mechanism ensures longer-lasting pain relief compared to traditional painkillers.
• Reduced Dependence on NSAIDs: Since frunevetmab does not affect cyclooxygenase enzymes, it has minimal impact on the gastrointestinal and renal systems.
• Selective Toxicity:
  Frunevetmab is selectively designed to target NGF, which is primarily involved in pain signaling in mammals, minimizing the risk of systemic side effects in dogs.